Long-acting Exparel helps reduce post-surgery pain, data show

09/2/2013 | Modern Medicine

Plastic surgery patients who took extended-release bupivacaine liposome injectable suspension, such as Exparel and Pacira, as an adjunct treatment to help control pain reported lower pain scores and used fewer opioid drugs, according to a study presented at the American Society for Aesthetic Plastic Surgery meeting. Plastic surgeon Stephan Finical of Charlotte Plastic Surgery, who wrote about the study in Cosmetic Surgery Times, said the drug worked well for patients having breast augmentation or reduction surgery or abdominoplasty, so he is "extending its use to facial cosmetic surgery."

View Full Article in:

Modern Medicine

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
MGR POST MARKET STUDIES - 14000001LK
Abbott
Santa Ana, CA
Regulatory Analyst
Delta Dental
Alpharetta, GA
Eastern Zone Sales Director
Regenesis Biomedical
Multiple Locations, SL_Multiple Locations
Senior Financial Analyst - Growing Manager Care Health Org
Fallon Community Health Plan
Worcester, MA
Associate Director, Regulatory Affairs - Promotional Review
Novo Nordisk
Princeton, NJ